ZURCHER KANTONALBANK FINANCE (GUERNSEY) LIMITED

Zurcher Kantonalbank Finance (Guernsey) Limited Share Price

Z0980Z

CH1329111327

Market Closed - Swiss Exchange 16:20:00 28/06/2024 BST
97.76 ^USD	+0.27%

3 months

-3.82%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart Zurcher Kantonalbank Finance (Guernsey) Limited

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Bristol-Myers Squibb to Pay $2.7 Million to Settle Potential Anti-Competition Case, Israeli Agency Says	07-01	MT
Bristol Myers Squibb Named to Dow Jones Sustainability Index North America	07-01	AQ
Purple Biotech Says Interim Data from Pancreatic Cancer Drug Study Shows Promise	06-27	MT
2seventy bio Sells Hemophilia A Candidate, Gene Editing Technology to Novo Nordisk; Shares Rise After Hours	06-26	MT

More news

Quotes 5-day view

Date	Price	Change
28/06/24	97.76	+0.27%
27/06/24	97.5	-0.58%
26/06/24	98.07	+0.51%
25/06/24	97.57	+0.62%

Delayed Quote Swiss Exchange

Last update June 28, 2024 at 04:20 pm

More quotes

Static data

Product type	Obligations Convertibles
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	ZKB
	Z0980Z
ISIN	CH1329111327
Date issued	11/03/2024
Strike	54.36 $
Maturity	11/03/2025 (253 Days)
Parity	0.05 : 1
Emission price	100 $
Emission volume	N/A
Settlement	les deux
Currency	USD

Technical Indicators

Highest since issue	101.6 $
Lowest since issue	95.97 $

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.3 USD

Average target price

53.19 USD

Spread / Average Target

+28.80%

Consensus